MAY 28-29, 2022


Corneal Confocal Microscopy: a Surrogate Endpoint for Neurodegeneration in Clinical Trials

Inna Eiberger , PhD

Inna Eiberger 

Director, Head M&TA Nerve Care Franchise
Global Medical and Technical Affairs, R&D 
Frankfurt Rhine, Germany

Dr Inna Eiberger is a Medical Affairs professional with more than 15 years of experience in the pharmaceutical industry. She holds a degree in pharmacy as well as a doctorate (“Dr. rer. nat.”) in pharmaceutical chemistry from the Gutenberg University in Mainz, Germany.

She has extensive experience and expertise in designing holistic medical strategies for specific disease areas for global brands. This includes the development of research programs, clinical trials, disease awareness campaigns and engagement strategies for health care professionals partnering with experts and scientific associations worldwide. In addition, she has broad experience in product development and innovation as well as in the development and implementation of medical strategies for the registration of medicinal products.

As a Medical Director within R&D at P&G Health, Inna leads a global medical team dedicated to the Nerve Care franchise, which includes products registered in more than 70 countries worldwide in the regions Asia-Pacific, Latin America, and Europe. 

Co-Sponsors